Research Study


Study Status: Active-Open to Enrollment

Study Name: ENHANCE

Study Focus: Alzheimer’s disease



Study Contact: To learn more, please call 1-877-854-8475 or fill out the Contact us form.

Study Purpose: The purpose of this study is to acquire a greater understanding of Alzheimer disease (AD). The exact pathology of AD is currently unknown. Previous research has suggested that certain abnormalities that can be found in analysis of blood are associated with the increased risk of AD.  We hope this research will promote the detection of new biomarkers that may lead to prevention, earlier diagnosis, and more effective treatments.

 To be enrolled in this study, you must meet certain requirements. You may be eligible to participate if you meet the following criteria:

  • New diagnoses of  Mild- Moderate Alzheimer’s disease
  • Must be at least 60 years old
  • Participant cannot be diagnosed with any chronic conditions including: diabetes (sugar problems) and    heart condition 

Study Duration:  up to 4 weeks

Study Commitment: The study consists of a total of 3 visits to the TRI-MD facility. The visits include:

  • 1 Screening visit
  • 1 Study visit (MRI , DEXA & blood collection)
  • 1 Follow-up visit (discussion of clinical findings with participant)

Study Procedures:        

  • Cognitive and depression assessment
  • Blood collection
  • Brain Imaging MRI         
  • Dual Energy X-ray Absorptiometry (DEXA) to measure body composition

Compensation offered? Yes

This study is being conducted under the direction of Dr. Steven Smith, MD at 301 East Princeton Street, Orlando, Florida 32804.